• Title/Summary/Keyword: Peptide-type toxin

Search Result 4, Processing Time 0.021 seconds

Botulinum toxin A의 임상적 적용원리 및 기본원칙

  • Choe, Jin-Yeong
    • The Journal of the Korean dental association
    • /
    • v.41 no.12 s.415
    • /
    • pp.826-830
    • /
    • 2003
  • botulinum toxin type A는 anaerobic bacterium clostridium botulinum에서 유래된 poly peptide neurotoxin으로서 사시, 안면연축, 수부다한증등에 치료목적으로 안정적으로 사용되어오다 최근에는 이마주름, 눈가주름등 주름살의 개선 목적으로 널리 사용되어 오고있다. 특히 턱얼굴외과 영역에서는 이러한 주름살의 개선이외에도 사각턱, 안면 신경의 이상으로 인한 안면 비대칭등 적용범위가 상당히 넓고 치료효과도 만족할 만하다고 하겠다. 이에 턱얼굴외과의사 나아가 치과의사들의 많은 사용을 기대하여 botulinum toxin 사용의 역사적 배경, 약리 및 작용기전, 가능한 합병증, 턱얼굴영역에서의 적용가능성 등에 대해 알아보고자 한다.

  • PDF

Analgesic Effect of Botulinum Toxin on Neuropathic Pain after Trigeminal Nerve Injury (삼차신경 손상에 의한 신경병증성 통증에서 보툴리눔 독소의 진통 효과)

  • Kim, Young-Gun;Kim, Seong-Taek
    • Journal of Dental Rehabilitation and Applied Science
    • /
    • v.28 no.2
    • /
    • pp.171-178
    • /
    • 2012
  • Botulinum toxin type A (BoNT-A) has been applied successfully to treat chronic migraine, dystonia, spasticity and temporomandubular disorders(TMDs) as well as frontal wrinkle and glabella wrinkle. Recently it has been reported that BoNT-A, reversibly blocks presynaptic acetylcholine release, also inhibits the release of substance P, CGRP(calcitonin gene related peptide) and glutamate related to peripheral sensitization and neurogenic inflammation in sensory nerve, In this study we reviewed animal nerve injury model such as rat and rabbit and identify the analgesic effect and mechanism of nerve injury pain after dental treatment.

Microcystins and Nodularin in Agricultural Products: Toxicity, Analytical Methods, Contamination Pathway, Occurrence, and Safety Management (농산물 내 마이크로시스틴과 노둘라린: 독성, 분석법, 오염 경로, 오염 현황 및 관리 동향)

  • Su Been Park;Sang Yoo Lee;Ji Eun Park;Jae Sung Kim;Hyang Sook Chun
    • Journal of Food Hygiene and Safety
    • /
    • v.39 no.3
    • /
    • pp.191-208
    • /
    • 2024
  • The peptide-type hepatotoxins microcystins (MCs) and nodularin (NOD) are secondary metabolites produced by cyanobacteria. MCs and NOD can bioaccumulate in agricultural products through toxin-contaminated water, soil, and manure and can cause human health risks through the consumption of agricultural products. As interest in the contamination of agricultural products by MCs or NOD has recently emerged, occurrence studies based on various analysis methods for agricultural products have been conducted. However, studies on agricultural products are still insufficient compared to research on drinking water and seafood. In addition, research is primarily conducted on agricultural products grown in areas where green algae occur, but not on marketed products. In the present study, we review the physicochemical properties, toxicity, analysis methods, occurrence studies, and management status of MCs and NOD in agricultural products to build a foundation for systematic monitoring and safety management.

Expression, Purification and Transduction of PEP-1-Botulinum Neurotoxin Type A (PEP-1-BoNT/A) into Skin

  • Kim, Dae-Won;Kim, So-Young;An, Jae-Jin;Lee, Sun-Hwa;Jang, Sang-Ho;Won, Moo-Ho;Kang, Tae-Cheon;Chung, Kwang-Hoe;Jung, Hyun-Ho;Cho, Sung-Woo;Choi, Jin-Hi;Park, Jin-Seu;Eum, Won-Sik;Choi, Soo-Young
    • BMB Reports
    • /
    • v.39 no.5
    • /
    • pp.642-647
    • /
    • 2006
  • Botulinum neurotoxin A (BoNT/A) has been used therapeutically to treat muscular hypercontractions and sudomotor hyperactivity and it has been reported that BoNT/A might have analgesic properties in headache. PEP-1 peptide is a known carrier peptide that delivers fulll-ength native proteins in vitro and in vivo. In this study, a BoNT/A gene were fused with PEP-1 peptide in a bacterial expression vector to produce a genetic in-frame PEP-1-BoNT/A fusion protein. The expressed and purified PEP-1-BoNT/A fusion proteins were efficiently transduced into cells in a time- and dose-dependent manner when added exogenously in a culture medium. In addition, immuno-histochemical analysis revealed that PEP-1-BoNT/A fusion protein efficiently penetrated into the epidermis as well as the dermis of the subcutaneous layer, when sprayed on mice skin. These results suggest that PEP-1-BoNT/A fusion protein provide an efficient strategy for therapeutic delivery in various human diseases related to this protein.